Abstract
We describe a 67-year-old man with a history of Stage B1 adenocarcinoma of the prostate who was treated with iodine-125 implantation in 1985. His prostate-specific antigen values subsequently increased in conjunction with an intraprostatic recurrence. Biopsy revealed primary squamous cell carcinoma arising in the prostate; no adenocarcinomatous elements were noted.
MeSH terms
-
Adenocarcinoma / pathology
-
Adenocarcinoma / radiotherapy*
-
Aged
-
Brachytherapy / adverse effects
-
Carcinoma, Squamous Cell* / diagnosis
-
Humans
-
Iodine Radioisotopes / adverse effects
-
Male
-
Neoplasm Staging
-
Neoplasms, Second Primary*
-
Prostate-Specific Antigen / analysis
-
Prostatic Neoplasms / diagnosis
-
Prostatic Neoplasms / radiotherapy*
Substances
-
Iodine Radioisotopes
-
Prostate-Specific Antigen